Prion detection by an amyloid seeding assay
- David W. Colby*,
- Qiang Zhang*,†,
- Shuyi Wang*,
- Darlene Groth*,
- Giuseppe Legname*,‡,
- Detlev Riesner§, and
- Stanley B. Prusiner*,¶,‖
- *Institute for Neurodegenerative Diseases and
- ¶Departments of Neurology and Biochemistry and Biophysics, University of California, San Francisco, CA 94143; and
- §Institut für Physikalische Biologie, Heinrich-Heine Universität, 40225 Düsseldorf, Germany
-
Contributed by Stanley B. Prusiner, October 25, 2007 (received for review September 18, 2007)
Abstract
Polymerization of recombinant prion protein (recPrP), which was produced in bacteria, into amyloid fibers was accompanied by the acquisition of prion infectivity. We report here that partially purified preparations of prions seed the polymerization of recPrP into amyloid as detected by a fluorescence shift in the dye Thioflavin T. Our amyloid seeding assay (ASA) detected PrPSc, the sole component of the prion, in brain samples from humans with sporadic Creutzfeldt–Jakob disease, as well as in rodents with experimental prion disease. The ASA detected a variety of prion strains passaged in both mice and hamsters. The sensitivity of the ASA varied with strain type; for hamster Sc237 prions, the limit of detection was ≈1 fg. Some prion strains consist largely of protease-sensitive PrPSc (sPrPSc), and these strains were readily detected by ASA. Our studies show that the ASA provides an alternative methodology for detecting both sPrPSc and protease-resistant PrPSc that does not rely on protease digestion or immunodetection.
Footnotes
- ‖To whom correspondence should be addressed. E-mail: stanley{at}ind.ucsf.edu
-
Author contributions: D.W.C., Q.Z., G.L., D.R., and S.B.P. designed research; D.W.C., Q.Z., S.W., and D.G. performed research; D.W.C. and S.B.P. analyzed data; and D.W.C. and S.B.P. wrote the paper.
-
↵ †Present address: Buck Institute for Age Research, Novato, CA 94945.
-
↵ ‡Present address: Neurobiology Sector, Scuola Internazionale Superiore di Studi Avanzati, Trieste 34012, Italy.
-
Conflict of interest statement: D.G., G.L., D.R., and S.B.P. have financial interest in InPro Biotechnology, Inc.
-
This article contains supporting information online at www.pnas.org/cgi/content/full/0710152105/DC1.
- © 2007 by The National Academy of Sciences of the USA





